RICHMOND, Va. (December 20, 2019) – Virginia Governor Ralph Northam presented his budget for Fiscal Years 2020-2022, which includes $11,143,500 for the Hampton University Proton Therapy Institute (HUPTI). The proposed funds will support the Institute’s life-saving efforts including proton therapy to treat cancerous tumors with fewer side effects to traditional cancer treatments, proton research and therapy activities.
“Cancer has replaced cardiovascular disease as a leading cause of death in the Commonwealth of Virginia. Additionally, Hampton Roads leads the nation in prostate cancer deaths. I want to thank Governor Northam for recognizing cancer as the terrible disease that it is and endeavoring to do something about it. His inclusion of the Hampton University Proton Therapy Cancer Institute in his 2020-2022 budget is a wonderful step in curing those citizens who have that terrible disease of cancer. Hopefully, the next Virginia General Assembly will support his request which will help us ease human misery and save lives,” said Dr. William R. Harvey, Hampton University President.
Governor Northam’s proposal, which invests in K-12 education, affordable housing, protecting Virginia’s environment and more, is the most progressive in Virginia’s history. The proposal aims to make significant investments in key priorities while maintaining strict fiscal responsibility.
“The budget I present to you today is structurally balanced. And it is cautious- we are forecasting our revenue to grow around 4 percent each year over the biennium, which is a more conservative forecast than the two General Assembly budget committees,” Governor Northam said in his address. “This strong economy enables us to increase funding in areas that have been neglected, while better positioning Virginia for the future.”
The Hampton University Proton Therapy Institute is committed to the latest in cancer-fighting technologies, as well as a continued focus on excellence in patient care. HUPTI treats breast, lung, prostate, head and neck, ocular, GI, brain and spine and pediatric cancers. It is the largest free-standing proton therapy facility in the world.